Navigation Links
Report answers questions about E. coli: The good, the bad and the deadly
Date:11/15/2011

It has been the cause of infamous international foodborne disease outbreaks and yet it is the most studied bacterium in science, an essential part of the human digestive tract, and a backbone of the biotech industry. To enhance public understanding of the bacterium Escherichia coli, the American Academy of Microbiology brought together the nation's leading experts to consider and answer some of the most frequently asked questions about this multifaceted microorganism.

"The story of E. coli, what we are trying to tell in this report, is really much larger than just its role as a pathogen. It's been such a large component of research for so long so much of what we know about biology has come from studying E. coli," says Michael Doyle of the University of Georgia Center for Food Safety, a member of the steering committee.

The report, entitled FAQ E.coli: Good, Bad and Deadly is based on the deliberations of 13 of the nation's leading experts who met for one day in September 2011 to develop clear answers to frequently asked questions regarding the role of E. coli in scientific research, human health and foodborne disease.

Some of the questions considered by the report are:

  • What is E. coli anyway?
  • How has E. coli contributed to our understanding of biology?
  • What does naturally occurring E. coli in our GI tract do?
  • What is the difference between "good" E. coli that inhabits our GI tract and the "bad" E. coli that makes us sick?
  • Why does E. coli make some people sick and not others?
  • How does E. coli become pathogenic?
  • How does our food become contaminated with E. coli?
  • What steps are being taken to protect our food from contamination by pathogenic E. coli?
  • What types of food are most commonly associated with E. coli, and why do there seem to be more cases of contamination recently?

Most answers begin with a simple paragraph summarizing what is known, followed by a more detailed explanation. In addition, spread throughout the report are sidebar boxes discussing issues related to the questions such as a list of Nobel Prizes awarded for work done on E. coli and a discussion of toxins created by the bacterium.

FAQ E. coli: Good, Bad and Deadly is the latest offering in a series of reports designed to provide a rapid response to emerging issues. Traditionally Academy reports are based on multi-day colloquia after which the final report can take up to a year to develop. The FAQ series are based on single-day meetings focused on specific questions after which a final report is published in 2-3 months.

"The Academy FAQ reports explain complex microbiological problems in a timely, balanced format that is easily understandable by the public, the media and policy makers," says Stanley Maloy of San Diego State University, who moderated the colloquium.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. New report offers broad approach to assessing impacts of ecological damage
2. Report provides new analysis of carbon accounting, biomass use, and climate benefits
3. BGI reports pig parasites genomic sequence provides new clues for parasitic diseases research
4. Aware, Inc. Reports Third Quarter 2011 Financial Results
5. Extreme melting on Greenland ice sheet, reports CCNY team
6. Scientists report major advance in human antibody therapy against deadly Hendra virus
7. Notre Dame researchers report progress on compound to treat neurological diseases
8. Study reports predictors of poor hand hygiene in an emergency department
9. Report showcases success of integrated development approaches
10. Reports highlight the evolving role of clinical microbiology laboratories
11. Researchers report new understanding of role of telomeres in tumor growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
Breaking Biology Technology: